Gram-positive Staphylococcus aureus is colonizer bacteria that, once they have colonized on human skin, produce a wide range of skin illnesses. Skin infections caused by S. aureus are partly ascribed to the pathogen's capacity to elude the host immune response and, more recently, to the emergence of antibiotic resistance. From simple skin infections like impetigo and infected abrasions to more complicated and invasive infections like cellulitis and infection of wounds and ulcers, folliculitis, and subcutaneous abscesses, this bacteria is known for its infections [1,2]. The high prevalence of these infections, together with microorganisms resistant to antibiotics, such as S. aureus that is resistant to methicillin and community-acquired MRSA infections, constitute a concern to public health [3,4].   This review paper will focus on the crucial interactions between the pathogen and host during the pathogen's adherence and colonization, as well as the subsequent infection, which is determined by the virulence factors of the bacteria and the skin's architecture. Although S. aureus is mostly a skin commensal, it may also cause serious skin infections when given the right opportunity, which makes treating it extremely difficult.

When a microbe is present on a particular area of the host, the pathogen multiplies and grows there, but it is not truly in an interactive or infectious stage. The prevalent bacterium known as S. aureus that typically colonizes human skin is present on the skin. Because of its many adhesion molecules, which include proteins and enzymes and work together to thwart the host immune response, it is truly credited with colonizing the area. The most significant location for S. aureus colonization is the nose [5]. However, the bacteria can also be found on the skin, especially on the hands, chest, and abdomen, as well as in the axillae, perineum, and throat. [6,7]. About 20% of the population has persistent S. aureus colonization, 30% has transitory S. aureus carriage, and roughly 50% are not carriers [8,9]. Children have higher rates of persistent carriage than adults [4]. Remarkably, persistent carriage rates have decreased over time, most likely as a result of better personal hygiene.

The pH and temperature of the skin's surface are low enough to prevent microbial growth [8,9]. It has been shown that during epidermal growth, the breakdown of the structural component filaggrin into urocanic acid and pyrrolidone carboxylic acid occurs with special significance to S. aureus [10]. It has been discovered that these breakdown products stop S. aureus from growing and reduce the bacterial factors that are involved in colonization, namely fibronectin binding protein A and clumping factor B (ClfB) [10].

Figure 1.

Pathogenesis of Staphylococcus Aureus on Human Skin

The expression of several extracellular and cell surface-associated proteins by S. aureus may be a factor in its pathogenicity. The pathophysiology of most diseases caused by this bacterium is complex and complicated. As such, it is challenging to pinpoint the exact contribution of any particular aspect. This also illustrates how inadequate many animal models of staphylococcal infections are. On the other hand, strains obtained from certain disorders have correlations with the expression of specific components, indicating their potential significance in pathogenesis. Certain toxins have the ability to replicate human disease symptoms in animals that have access to purified proteins. Recent developments in our knowledge of the pathophysiology of staphylococcal illnesses are a result of the use of molecular biology. Potential virulence factor-encoding genes have been cloned, sequenced, and protein purified. This has made it easier to study their mechanisms of action at the molecular level in both in vitro and model system settings. Furthermore, in animal models, the pathogenicity of the mutants was evaluated in comparison to the wild-type strain, and genes encoding potential virulence factors were rendered inactive. Any decrease in virulence suggests that something is lacking. The "Molecular Koch's Postulates" have been satisfied if the mutant's virulence is reinstated upon receiving the gene back. This method has confirmed a number of S. aureus pathogenicity factors.

S aureus Adheres to Host Proteins

Laminin and fibronectin, two host proteins that are a component of the extracellular matrix, are seen on S. aureus cell surfaces. To facilitate adhesion (Figure below). Both endothelial and epithelial surfaces include fibronectin, which is also a constituent of blood clots. Furthermore, the majority of strains exhibit the clumping factor, a fibrinogen/fibrin binding protein that facilitates attachment to injured tissue and blood clots. Fibronectin and proteins that bind fibrinogen are shown by the mostly S aureus strains.

Figure 2.

In particular, strains that cause septic arthritis and osteomyelitis are linked to the receptor that facilitates attachment to collagen. Coordination with collagen is additionally important when bacterial adhesion is encouraged to wounded tissue where the layers beneath are exposed.

Staphylococcal matrix-binding proteins have been shown to contribute to pathogenicity in vitro adherence assays and experimental infections using defective mutants. Mutants with decreased virulence when lacking in binding to both fibrinogen and fibronectin in a rats model of endocarditis suggest that these two proteins aid in bacterial attachment to the sterile vegetation produced by destruction of the endothelium surface of the heart valve. Mutants lacking the collagen-binding protein seem to be less harmful in the mouse form of septic arthritis [11,12].

Avoidence of Host Defense

Several components that could potentially disrupt host defensive processes are expressed by S. aureus. Nevertheless, there is insufficient proof to support these elements' involvement in virulence.

Capsular Polysaccharide

A surface polysaccharide of serotype 5 or 8 is expressed by most of the clinical isolates of S. aureus. This is called a microcapsule because it is only visible by electron microscopy after antibody labeling, in contrast to the many capsules from other bacteria which can be viewed by light microscopy. In S. aureus extracted from infections, high amounts of polysaccharide are produced, but they are rapidly lost during lab subculturing. The capsule's purpose is unclear. Although in vitro testing only showed this to occur in a lack of complement, it might hinder phagocytosis. In contrast, polysaccharide expression may actually hinder the colonialism of injured valves of heart by concealing adhesin proteins, as demonstrated by a comparison between wild-type and a mutant strain with a faulty capsule in an endocarditis model.

Protein A

Protein A is the outermost protein of the bacteria Staphylococcus aureus that binds to the Fc domain of immunoglobulin G molecules. Serum bacteria will attach IgG molecules the wrong way through this non-immune mechanism. In theory, this should obstruct phagocytosis and opsonization. Actually, studies using mutations in infection models suggest that protein an increases pathogenicity; in vitro, S aureus mutants lacking protein a are more efficiently phagocytized.

Leukocidin

A toxin that selectively affects polymorphonuclear leukocytes is expressed by S aureus. As phagocytosis is an essential defense strategy against staphylococcal infection, leukocidin ought to be regarded as a virulence factor. The following section goes into further depth about this poison.

Damage to the Host

Multiple protein toxins that S aureus expresses are likely what cause the symptoms that arise during an infection. Hemolysis is the result of certain substances damaging erythrocyte membranes; nevertheless, hemolysis is rare to occur in vivo. Leukocytes are damaged by the leukocidin, which is not hemolytic. Toxic shock is caused by enterotoxins and TSST-1, while septic shock is caused by the systemic release of α-toxin.

Αlpha-Toxin(α)

 It is one of most powerful as well well-characterized toxin that damages membranes in S aureus. It is made as a monomer that clings to the membrane of susceptible cells. Subunits then oligomerize to form hexameric rings with an inner pore that lets cell contents out.

The α-toxin receptor on susceptible cells binds to the toxin at low doses to create tiny pores that let monovalent cations pass through. When the toxin combines with lipids in the membrane at higher doses, it forms larger pores that let divalent cations and small molecules through. Under typical physiological circumstances, it is unlikely that this would matter. Platelets and monocytes in humans are especially vulnerable to α-toxin. Because of their high affinity locations, toxins can attach to them at physiologically relevant amounts. The production of inflammatory mediators is triggered by a complex series of secondary events that result in the release of eicosanoids and cytokines. Severe S. aureus infections result in septic shock symptoms, which are brought on by these circumstances.

The hypothesis that S aureus's main virulence factor is α-toxin is supported by studies conducted on animals and cultures of organs utilizing the pure toxin. Mutants lacking α-toxin demonstrate decreased pathogenicity in many animal infection models [13].

β-Toxin

The membranes rich with this lipid are damaged by β-toxin, a sphingomyelinase. Sheep erythrocyte lysis is the traditional method of testing for β-toxin. β-toxin is not expressed by a large proportion of S aureus strains from humans. A lysogenic bacteriophage is inserted to modify the gene that codes for the toxin. The process known as negative phage transformation is described. The determinant for staphylokinase and an enterotoxin is present in some of the phages that turn the β-toxin gene inactive.

Sigma-Toxin(δ)

Prod by the majority of S aureus strains, the δ-toxin is a little peptide toxin. S. epidermidis and S. lugdunensis also generate it. Unknown is the function of δ-toxin in illness.

Leukocidins and Γ-Toxins

Leukocidins and γ-toxins are two types of protein toxins that damage the membranes of cells that are susceptible to injury. Despite being expressed separately, the proteins work together to harm membranes. There isn't any proof that they create multimers before entering membranes. The locus for γ-toxin expresses three proteins. A leukotoxin with minimal hemolytic activity is produced by components B and C, whereas component A and B both are hemolytic and mildly leukotoxic. The leukotoxin produced by the γ-toxin locus is not the same as the traditional Panton and Valentine (PV) leukocidin. Unlike γ-toxin, it is non-hemolytic and possesses strong leukotoxicity. While 90% of S aureus isolates from severe dermonecrotic lesions express this toxin, only 2% of S aureus isolates from one survey express PV leukocidin. This suggests that a major factor in the necrosis of of skin infections is PV leukocidin.

PV-leukocidin causes dermonecrosis when given subcutaneously into rabbits. Furthermore, at lower doses than those that cause membrane disruption and degranulation, human neutrophils respond to the toxin by releasing inflammatory mediators. This could provide an explanation for the infiltration, vasodilation, and central necrosis histology linked to dermonecrotic infections [13].

Toxin (Exfoliative) (ET)

 In newborns, this toxin results in the scalded skin condition, which includes extensive blistering and epidermal loss. The toxin comes in two antigenically different forms: Exfoliative toxin A and Exfoliative toxin B. It is proved that the protease action of these poisons exists. The three most important amino acids present in the protease's site of action are retained by both toxins, which have sequences similar to those of the S aureus serine protease. Furthermore, by replacing the serine site of action with a glycine, the toxin action was totally eliminated. ETs do, however, exhibit esterase activity but not much proteolytic activity.  It is unknown how the latter produces epidermal splitting. It's possible that one of the proteins that toxins specifically target is crucial for maintaining the integrity of the epidermis.

Coagulase

Enzymes don't include coagulase. This extracellular protein attaches itself to the prothrombin of the host to produce a complex called staphylothrombin. Fibrinogen transforms into fibrin in a complex when the thrombin- specific protease activity is triggered. The tube coagulase examination operates on this abecedarian principle, in which a tube is placed incubated with the S aureus broth-culture supernatant and a clot is subsequently formed. Coagulase is a commonly utilized marker in medical microbiology labs for S aureus identification.

It’s presumptive to hypothecate that the bacteria could use localized clotting to shield themselves from host defenses, but there's no evidence that this is an acridity element. Specially, in multiple infection scripts studied, coagulase imperfect mutants showed no changes from the parent strain. The determinant that binds fibrinogen on the surface of S aureus bacteria, cementing factor, and coagulase isn’t well understood in the literature. A portion of this can be attributed to squishy title; the cementing element is sometimes called set coagulase. Even though coagulase is allowed to exist as an external protein, a tiny piece of it is firmly attached to the bacterial cell surface so that it can respond with prothrombin. Incipiently, it has been demonstrated lately that the coagulase, at least when it's extracellular, can bind fibrinogen in addition to thrombin. Coagulase and cementing factor are easily two different effects, according to inheritable exploration. Certain cementing factor mutants express coagulase typically, but coagulase-deficient mutants maintain cementing factor exertion.  Staphylokinase is a plasminogen activator that's expressed by multitudinous strains of S aureus. Lysogenic bacteriophages are linked to the inheritable determinant.

Staphylokinase

Plasminogen and staphylokinase combine to induce a complex that triggers plasmin- suchlike proteolytic exertion, which dissolves fibrin clots. The medium is the same as that of streptokinase, a drug used to treat cases with thrombosis in the heart. Analogous to coagulase, staphylokinase doesn't appear to be an acridity factor, while it's conceivable that localized fibrinolysis could contribute to the spread of bacteria.

Enzymes

Enzymes Deoxyribonuclease( DNase), lipase, proteases, and adipose acid modifying enzymes( FAME) can all be expressed by S aureus. It's unclear that the first three play further than a supporting part in pathogenesis; they most probably give the bacteria aliment. In abscesses, on the other hand, the FAME enzyme might play a pivotal part by altering antibacterial lipids and extending bacterial life. An essential individual tool for determining S aureus identity is the thermostable DNase.    

Host Immune Defense against the Bacteria

The skin is the biggest organ in the human body and the main physical barrier that isolates the organism from its environment [14]. It also actively contributes to the host's defense, which in turn affects the initiation and maintenance of inflammatory and immunological responses locally [14]. This tissue acts as the entry point for numerous foreign antigens, triggering a variety of immunological responses [14]. Important cells found in the skin include T lymphocytes, Langerhans, and melanocytes. Immune system cells known as Langerhans are immature DCs, and their job is to collect antigens that make their way into the host's skin.

Role of Keratinocytes

The core cells of the epidermis, known as keratinocyte cells, serve as a barrier against bacteria and other outside invaders [15]. Typically, keratinocyte cells are the first to come into contact with microbial pathogens. To discover Pathogen-Associated Molecular Patterns (PAMPs), they employ a range of Pattern-Recognition Receptors (PRRs), such as TLRs, the scavenger receptors CD36, nucleotide-binding oligomerization domain-1 (NOD-1), and nucleotide-binding oligomerization domain -2 (NOD -2] [15,16]. Signaling is responsible for inducing the synthesis of chemokines, cytokines, and antimicrobial effectors, including antimicrobial peptides (AMPs) and inducible nitric oxide synthase, through these human receptors.

Role of Neutrophils

The human immune system's second line of nonspecific defense is made up of phagocytic white cells called neutrophils, which have chemotaxis [17]. One of the most important components of the acute response and one that is directly related to S. aureus is the neutrophil [18]. The intracellular PRRs that recognized microbial peptidoglycan, NOD-1, and NOD-2, increase the synthesis of antibacterial peptide inflammatory processes, and phagocytic effector activities [19]. The peptidoglycan of S. aureus contains muramyl-dipeptide, which is recognized by NOD-2 molecules [20, 21].

Role of Different AMPS

A few AMPs that are active against S. aureus cells are found in human skin. These include RNase7, dermcidin, beta-defensins, cathelicidin, and alpha-defensins, sometimes known as HNPs (human neutrophil peptides) [22,23]. High concentrations of HNPs, including over half of the peptides found in neutrophil granules, are released by neutrophils [24]. Regarding S. aureus cells, HNP2 peptides exhibit the strongest antibacterial activity among HNPs [25]. hBD1, hBD2, hBD3, and hBD4 are the four distinct types of human β-defensins (hBDs). These are generated by keratinocytes, macrophages, and DCs. [26, 27]. hBD3 is one of the hBDs with the strongest action against S. aureus [28]. Comparable to hBD3, which is made up of 37 amino acids that are liberated from the 18 kDa cationic antibacterial protein [29], Similar to hBD3, cathelicidin is often referred to as LL-37 and exhibits potent anti-S. aureus action. [30].

Adaptive Immunity against the Pathogen

Function of B cells

Known by another name, B cells, or B lymphocytes, are a subset of immune cells that produce antibodies to fight viruses and other infections [31]. Together with cellular immunity, these specialized lymphocytes form humoral immunity, which is an effective defensive mechanism [32]. Antibody-deficient lymphocytes are first activated by antigenic interactions, presenting as Antigen-Presenting Cells (APCs) in response to antigens, before differentiating into memory cells.  When the same antigen is re exposed, memory cells have the capacity to produce more antibodies quickly.

Function of T cells

T cells have two roles: they help to mature antibody affinity and enable class switches, which are important for producing antibodies with opposing functions. In addition, T cells assist in phagocytosis by luring bone marrow-derived neutrophils and macrophages to the infection site [33]. T-cell cytokines, specifically IFN-γ, facilitate the elimination of S. aureus from the macrophage [33]. Next, NK cells or Cytotoxic Cells (CT) cells need to lyse the infected cell [34]. In the end, T cells' suppression of inflammatory processes is a critical factor in reestablishing immunological homeostasis [34].

Antimicrobial Resistance

Staphylococci's resistance to antimicrobial drugs Sanitarium S. aureus strains consistently demonstrate resistance to numerous antibiotics. There have been strains linked that are resistant to every therapeutically effective drug, with the exception of the glycopeptides teicoplanin and vancomycin. Methicillin- resistant strains are appertained to as MRSAs since utmost of them are also multiply resistant. There have been cases of enterococci displaying vancomycin resistance coupled with plasmids; in the laboratory, enterococci have transferred this resistance determinant to S aureus and it can also develop spontaneously. Methicillin resistance is a common particularity in S epidermidis nosocomial isolates, among other antibiotic resistances. 

1. aureus has snappily developed resistance to new medicines since the dawn of the antibiotic period. Numerous inheritable mechanisms have contributed to the acquisition of this resistance, including
2. Obtaining redundant inheritable information on chromosomes and extrachromosomal plasmids by the use of transposons and other DNA insertion methods.
3. Gene mutation in the chromosomes.

Recent chromosomal inserts of several plasmid- decoded determinants have passed at a position linked to the methicillin resistance determinant. The organism may profit from enjoying chromosomal resistance determinants since they're going to be morestable.In bacteria, resistance to antibiotics basically occurs through four mechanisms

1. Medicine inactivation through enzymatic means
2. Medicine target variations to avoid list
3. Increased medicine efflux to avoid poisonous attention erecting up in the cell
4. Medicine- resistant target expression through a by- pass medium [35]

In conclusion, understanding the pathogenesis of Staphylococcus aureus and its intricate relationship with human skin is paramount in addressing the challenges posed by this opportunistic pathogen. This thorough analysis focuses on the intricate mechanisms underlying S. aureus colonization, encroachment and the development of virulence factors, all of which enhance the pathogen's capacity to cause a variety of skin infections.

Furthermore, the thorough explanation of the host's immunological response, including the functions of neutrophils, AMPs, keratinocytes, and adaptive immunity, clarifies the dynamic interactions that occur among the pathogen and the host. This interplay is crucial for developing novel therapeutic interventions and enhancing existing treatment strategies.

The growing concern over antibiotic resistance-especially with regard to methicillin-resistant Staphylococcus aureus (MRSA), which presents serious public health issues-is also included in the review. Understanding and addressing this problem requires an understanding of the biological processes of antimicrobial resistance, which include the emergence of resistance genes, the function of plasmids, and chromosomal changes.   

 In conclusion, the insights gained from studying the pathogenesis and host interactions of S. aureus are essential for advancing therapeutic approaches and mitigating the impact of antibiotic resistance. Future research should continue to explore these areas to develop innovative solutions to manage and treat S. aureus infections effectively.

1. McCaig LF, McDonald LC, Mandal S, Jernigan DB. Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care. Emerging Infectious Diseases. 2006; 12: 1715-1723.
2. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB. EMERG Ency ID Net Study Group. Methicillin-resistant S. aureus infections among patients in the emergency department. The New England Journal of Medicine. 2006; 355: 666-674.
3. Daum RS. Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med. 2007; 357: 380-390.
4. Elston DM. Handling a community-acquired methicillin-resistant Staphylococcus aureus outbreak: emerging data. Cutis. Cutaneous Medicine for the Practitioner. 2008; 82: 13-17.
5. Ca AE, Smith JE. Carriage patterns of Staphylococcus aureus in a healthy non-hospital population of adults and children. Ann Hum Biol. 1976; 3: 221-227.
6. Wertheim HFL, Verveer J, Boelens HAM, van Belkum A, Verbrugh HA, Vos MC. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults. Antimicrob Agents Chemother. 2005; 49: 1465-1467.
7. Eriksen NH, Espersen F, Rosdahl VT, Jensen K. Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period. Epidemiol Infect. 1995; 115: 51-60.
8. Kluytmans JAJW, Wertheim HFL. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection. 2005; 33: 3-8.
9. Foster TJ, Mcdevitt D. Molecular basis of adherence of staphylococci to biomaterials. In AL Bisno & FA. Waldvogel (Eds.), Infections Associated with Indwelling Medical Devices. Washington, D.C.: American Society for Microbiology. 1994.
10. Haugwitz U, Bobkiewicz W, Han SR, Beckmann E, Veerachato G, Shaid S, et al. Pore-forming Staphylococcus aureus alpha-toxin triggers epidermal growth factor receptor-dependent proliferation. Cell Microbiol. 2006; 8: 1591-1600.
11. Prevost G, Couppie P, Prevost P, Gayet S, Petiau P, Cribier B, et al. Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol. 1995; 42: 237-245.
12. Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ. Skin immune sentinels in health and disease. Nat Rev Immunol. 2009; 9: 679-691.
13. Ibrahim F, Khan T, Pujalte GGA. Bacterial skin infections. Primary Care. 2015; 42: 485-499.
14. Amarante-Mendes GP, Adjemian S, Branco LM, Zanetti LC, Weinlich R, Bortoluci KR. Pattern Recognition Receptors and the host cell death molecular machinery. Front Immunol. 2018; 9: 2379.
15. Smith JA. Neutrophils, host defense, and inflammation: a double-edged sword. J Leukoc Biol. 1994; 56: 672-686.
16. Rigby KM, DeLeo FR. Neutrophils in innate host defense against Staphylococcus aureus infections. Seminars in Immunopathology. 2012; 34: 237-259.
17. Takada H, Uehara A. Enhancement of TLR-mediated innate immune responses by peptidoglycans through NOD signaling. Curr Pharm Des. 2006; 12: 4163-4172.
18. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem. 2003; 278: 8869-8872.
19. Schaffler H, Demircioglu DD, Kuhner D, Menz S, Bender A, Autenrieth IB. NOD2 stimulation by Staphylococcus aureus-derived peptidoglycan is boosted by Toll-like receptor 2 costimulation with lipoproteins in dendritic cells. Infect Immun. 2014; 82: 4681-4688.
20. van der Does AM, Hiemstra PS, Mookherjee N. Antimicrobial host defence peptides: Immunomodulatory functions and translational prospects. Adv Exp Med Biol. 2019; 1117: 149-171.
21. Prasad SV, Fiedoruk K, Daniluk T, Piktel E, Bucki R. Expression and function of host defense peptides at inflammation sites. Int J Mol Sci. 2019; 21: 104.
22. Glenthoj Am, Nickles K, Cowland J, Borregaard N. Processing of neutrophil α-defensins does not rely on Serine proteases in vivo. PloS One. 2015; 10.
23. Ericksen B, Wu Z, Lu W, Lehrer RI. Antibacterial activity and specificity of the six human α-defensins. Antimicrob Agents Chemother. 2005; 49: 269-275.
24. Kiatsurayanon C, Ogawa H, Niyonsaba F. The role of host defense peptide human β-defensins in the maintenance of skin barriers. Curr Pharm Des. 2018; 24: 1092-1099.
25. Schauber J, Gallo RL. Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol. 2009; 124: 13-8.
26. Otto M. Staphylococcus colonization of the skin and antimicrobial peptides. Expert Rev Dermatol. 2010; 5: 183-195.
27. Zhang M, Liang W, Gong W, Yoshimura T, Chen K, Wang JM. The Critical Role of the Antimicrobial Peptide LL-37/CRAMP in Protection of Colon Microbiota Balance, Mucosal Homeostasis, Anti-Inflammatory Responses, and Resistance to Carcinogenesis. Critical Reviews TM in Immunology. 2019.
28. Febriza A, Hatta M, Natzir R, Kasim VNA, Idrus HH. Activity of antimicrobial peptide; Cathelicidin on bacterial infection. Open Biochem J. 2019; 13: 45-53.
29. Boehm T, Hirano M, Holland SJ, Das S, Schorpp M, Cooper MD. Evolution of alternative adaptive immune systems in vertebrates. Annu Rev Immunol. 2018; 36: 19-42.
30. McHeyzer-Williams M, Okitsu S, Wang N, McHeyzer-Williams L. Molecular programming of B cell memory. Nature Reviews. Immunology. 2011; 12: 24-34.
31. Hirahara K, Vahedi G, Ghoreschi K, Yang XP, Nakayamada S, Kanno Y, et al. Helper T-cell differentiation and plasticity: insights from epigenetics. Immunology. 2011; 134: 235-245.
32. Broker BM, Mrochen D, Peton V. The T Cell Response to Staphylococcus aureus. Pathogens. 2016; 5: 31.
33. Lyon BR, Skurray R. Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiol Rev. 1987; 51: 88-134.